- Home
- GIGM vs PPBT Comparison
GIGM vs PPBT Comparison
Compare GIGM & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- PPBT
- Stock Information
- Founded
- GIGM 1998
- PPBT 2010
- Country
- GIGM Taiwan
- PPBT Israel
- Employees
- GIGM N/A
- PPBT N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- GIGM Technology
- PPBT Health Care
- Exchange
- GIGM Nasdaq
- PPBT Nasdaq
- Market Cap
- GIGM 17.9M
- PPBT 6.2M
- IPO Year
- GIGM 2000
- PPBT N/A
- Fundamental
- Price
- GIGM $1.44
- PPBT $2.53
- Analyst Decision
- GIGM
- PPBT Strong Buy
- Analyst Count
- GIGM 0
- PPBT 1
- Target Price
- GIGM N/A
- PPBT $33.00
- AVG Volume (30 Days)
- GIGM 14.5K
- PPBT 18.2K
- Earning Date
- GIGM 07-30-2025
- PPBT 08-15-2025
- Dividend Yield
- GIGM N/A
- PPBT N/A
- EPS Growth
- GIGM N/A
- PPBT N/A
- EPS
- GIGM N/A
- PPBT N/A
- Revenue
- GIGM $3,103,000.00
- PPBT N/A
- Revenue This Year
- GIGM N/A
- PPBT N/A
- Revenue Next Year
- GIGM N/A
- PPBT N/A
- P/E Ratio
- GIGM N/A
- PPBT N/A
- Revenue Growth
- GIGM N/A
- PPBT N/A
- 52 Week Low
- GIGM $1.27
- PPBT $2.00
- 52 Week High
- GIGM $1.80
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- GIGM 48.89
- PPBT 56.04
- Support Level
- GIGM $1.41
- PPBT $2.35
- Resistance Level
- GIGM $1.52
- PPBT $2.58
- Average True Range (ATR)
- GIGM 0.04
- PPBT 0.12
- MACD
- GIGM 0.01
- PPBT 0.02
- Stochastic Oscillator
- GIGM 40.60
- PPBT 84.38
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.